Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-25

Clinical Trial Update: Diclofenac Administered Before Skull Operations Reduces the Severity of Headache After the Intervention [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating diclofenac given before skull surgery showed a reduction in the severity of postcraniotomy headache after the procedure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac (diclofenac)

Snippet

Sponsor: University of Debrecen | Conditions: Postcraniotomy Headache, Intraoperative Analgesic Use | Phase 4 | Status: COMPLETED